Two Sigma Securities’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-584,800
| Closed | -$16.9M | – | 2815 |
|
|
2024
Q3 | $16.9M | Buy |
584,800
+56,500
| +11% | +$1.65M | 0.29% | 74 |
|
|
2024
Q2 | $14.8M | Sell |
528,300
-494,000
| -48% | -$13.6M | 0.18% | 126 |
|
|
2024
Q1 | $28.4M | Buy |
1,022,300
+256,400
| +33% | +$7.11M | 0.27% | 76 |
|
|
2023
Q4 | $22.1M | Buy |
765,900
+229,400
| +43% | +$6.93M | 0.21% | 98 |
|
|
2023
Q3 | $17.8M | Buy |
536,500
+382,400
| +248% | +$13.5M | 0.19% | 109 |
|
|
2023
Q2 | $5.65M | Sell |
154,100
-60,100
| -28% | -$2.34M | 0.08% | 255 |
|
|
2023
Q1 | $8.74M | Buy |
214,200
+113,700
| +113% | +$4.91M | 0.18% | 121 |
|
|
2022
Q4 | $5.15M | Sell |
100,500
-264,100
| -72% | -$12.7M | 0.15% | 146 |
|
|
2022
Q3 | $16M | Buy |
364,600
+52,700
| +17% | +$2.56M | 0.48% | 23 |
|
|
2022
Q2 | $16.4M | Buy |
311,900
+40,500
| +15% | +$2.06M | 0.58% | 24 |
|
|
2022
Q1 | $14.1M | Buy |
271,400
+239,600
| +753% | +$12.4M | 0.49% | 19 |
|
|
2021
Q4 | $1.88M | Sell |
31,800
-21,000
| -40% | -$1.04M | 0.08% | 132 |
|
|
2021
Q3 | $2.27M | Sell |
52,800
-28,500
| -35% | -$1.26M | 0.07% | 257 |
|
|
2021
Q2 | $3.18M | Buy |
81,300
+13,600
| +20% | +$529K | 0.1% | 150 |
|
|
2021
Q1 | $2.45M | Sell |
67,700
-101,700
| -60% | -$3.61M | 0.14% | 71 |
|
|
2020
Q4 | $6.24M | Buy |
169,400
+131,983
| +353% | +$4.84M | 0.15% | 79 |
|
|
2020
Q3 | $1.3M | Buy |
37,417
+7,905
| +27% | +$277K | 0.03% | 292 |
|
|
2020
Q2 | $916K | Sell |
29,512
-27,088
| -48% | -$920K | 0.02% | 425 |
|
|
2020
Q1 | $1.75M | Sell |
56,600
-222,921
| -80% | -$7.6M | 0.04% | 266 |
|
|
2019
Q4 | $10.4M | Buy |
279,521
+63,029
| +29% | +$2.25M | 0.07% | 220 |
|
|
2019
Q3 | $7.38M | Sell |
216,492
-50,275
| -19% | -$1.83M | 0.07% | 224 |
|
|
2019
Q2 | $11M | Buy |
266,767
+190,563
| +250% | +$7.57M | 0.11% | 108 |
|
|
2019
Q1 | $3.07M | Buy |
76,204
+37,733
| +98% | +$1.51M | 0.03% | 237 |
|
|
2018
Q4 | $1.59M | Sell |
38,471
-426,554
| -92% | -$17.7M | 0.02% | 445 |
|
|
2018
Q3 | $19.4M | Sell |
465,025
-747,286
| -62% | -$28.8M | 0.13% | 104 |
|
|
2018
Q2 | $41.7M | Buy |
1,212,311
+490,848
| +68% | +$16.8M | 0.21% | 59 |
|
|
2018
Q1 | $24.3M | Buy |
721,463
+662,017
| +1,114% | +$22.8M | 0.14% | 130 |
|
|
2017
Q4 | $2.04M | Buy |
+59,446
| New | +$2.03M | 0.05% | 262 |
|
Other funds holding PFE
VCM
VPM
Two Sigma Securities's PFE Position: Q1 2026 in Review
Two Sigma Securities sold out of Pfizer (PFE) in Q1 2026, closing a stake of 20,529 shares — an estimated $511K sold.
Two Sigma Securities first reported a position in PFE in Q1 2015 and held it in 34 quarters. The position peaked at $19.2M in Q4 2023. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Two Sigma Securities reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Two Sigma Securities sold 20,529 Pfizer shares in Q1 2026, an estimated $511K.
- Two Sigma Securities first reported a position in Pfizer in Q1 2015 and held it in 34 quarters.
- Two Sigma Securities's Pfizer position peaked at $19.2M in Q4 2023.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.